What is GestVision?
GestVision Inc. operates at the intersection of biotechnology and maternal health, specializing in the development of advanced diagnostic tools for preeclampsia. The company's flagship innovation, the GestAssured Test, is engineered to provide rapid, accurate identification of this life-threatening pregnancy complication. By addressing the critical need for early detection of high blood pressure and proteinuria, GestVision provides healthcare providers with actionable data to mitigate severe maternal and fetal outcomes. The firm occupies a vital niche in the prenatal monitoring market, aiming to standardize early intervention protocols through high-precision diagnostic technology.
How much funding has GestVision raised?
GestVision has raised a total of $7.2M across 2 funding rounds:
Angel/Seed
$100K
Private Equity
$7.1M
Angel/Seed (2014): $100K with participation from YEI Innovation Fund
Private Equity (2015): $7.1M, investors not publicly disclosed
Key Investors in GestVision
YEI Innovation Fund
A venture capital entity focused on identifying and scaling innovative solutions within the Chinese market, providing both financial backing and operational guidance to emerging technology firms.
Undisclosed Investor
An undisclosed institutional partner participating in the latest round of private equity financing to support the company's enterprise-level growth.
Undisclosed Investor
An undisclosed investor participating in the funding round.
What's next for GestVision?
With the recent infusion of capital, GestVision is expected to prioritize the scaling of its manufacturing capabilities and the expansion of its clinical trial footprint. The strategic roadmap likely involves securing regulatory clearances and establishing distribution partnerships with major hospital networks and prenatal care providers. As the company matures, the focus will shift toward long-term commercialization and the integration of its diagnostic platform into standard obstetric care workflows, ensuring that the GestAssured Test becomes a cornerstone of modern prenatal health management.
See full GestVision company page